Repligen | RGEN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agilent USD 32.66B 5.2B 2026-03
Align Technology USD 12.28B 1.07B 2026-03
Bio Techne USD 8.18B 987M 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Bruker USD 5.5B 1.66B 2026-03
Charles River Laboratories USD 7.85B 2.17B 2026-03
Danaher USD 128.46B 33.24B 2026-03
Dentsply International USD 2.32B 36M 2026-03
General Electric Aerospace USD 296.49B 28.42B 2026-03
Henry Schein USD 8.27B 689M 2026-03
Illumina USD 17.88B 2.74B 2026-03
IQVIA Holdings USD 28.63B 9.76B 2026-03
Mettler Toledo International USD 25.54B 2.94B 2026-03
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
Repligen USD 6.64B 2.58B 2026-03
Revvity USD 9.94B 1.03B 2026-03
Standard Biotools USD 319M 40M 2026-07
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Waters USD 29.87B 7.25B 2026-03
West Pharmaceutical Services USD 18.07B 1.73B 2026-03